Physician profile
Michael Kent Smith
NPI 1396879508
$868.36
in general payments reported to CMS, 2019-2025
12 companies · $17.04 in 2025
The $17.04 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.41 · 2020: $158 · 2021: $13.20 · 2022: $25.59 · 2023: $575 · 2024: $7.17 · 2025: $17.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $214 · Consulting Fee: $200 · Food and Beverage: $123 · Honoraria: $45.39 · Education: $16.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $214.47 |
| Consulting Fee | $200.00 |
| Food and Beverage | $122.96 |
| Honoraria | $45.39 |
| Education | $16.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $221.64 | 2023-2024 | Opalescence |
| Dentsply LLC | $200.00 | 2023 | |
| Implant Direct Sybron International LLC | $89.78 | 2020 | |
| Align Technology, INC. | $79.43 | 2022-2023 | Invisalign |
| Septodont INC. | $54.01 | 2020 | |
| Henry Schein, INC. | $48.45 | 2019 | |
| Benco Dental Supply Co. | $45.39 | 2023 | |
| Philips North America LLC | $42.07 | 2019-2025 | Oral Health Care Undivided |
| Dentsply Sirona INC | $40.28 | 2019-2023 | Suresmile |
| Nobel Biocare USA | $16.76 | 2023 | Nobelactive |
| Kerr Corporation | $16.76 | 2023 | Maxcem Elite |
| Orapharma, A Division of Bausch Health US, LLC | $13.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.